Pharmacokinetics and Pharmacodynamics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Graft-versus-host disease
- Focus Pharmacokinetics
- 01 Nov 2019 Status changed from completed to discontinued.
- 01 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2013 New trial record